Week 4 Midterm Exam: NR546 NR-

Week 4 Midterm Exam: NR546 / NR-

546 (Latest 2025 / 2026) Advanced Pharmacology Psychopharmacology for the PMHNP | Questions and Answers | 100% Correct | Grade A - Chamberlain

Question:

Which NTM is targeted by azapirones/buspirone

Answer:

5HT, DA, NE

Question:

S/E of buspirone

Answer:

dizziness HA sedation nervousness nausea 1 / 4

Question:

Monitoring of buspar

Answer:

severe renal and hepatic impairment concurrent use of MAOIs

Question:

True or false buspar causes sexual s/e

Answer:

false. Buspar may decrease sexual se when used in combination with an SSRI

Question:

MOA of Alpha 2 delta ligands

Answer:

bind with glutamate calcium change blockers to inhibit the release of several neurotransmitters

Question:

Alpha 2 delta ligands are FDA approve for treatment of anxiety

Answer:

False. Alpha 2 delta ligands are used off label for treatment of anxiety

• / 4

Question:

MOA of pregabalin for anxiety

Answer:

binds to the alpha 2 delta subunit of voltage-sensitive calcium channels.diminishing excessive neuronal activity and NTM release

Question:

Which drugs are alpha 2 delta ligands

Answer:

gabapentin, pregabalin

Question:

S/E of Alpha 2 delta ligands

Answer:

sedation dizziness impaired attention confusion dry mouth constipation blurred vision possible weight gain

• / 4

Question:

Precautions for A2 delta ligands

Answer:

suicidal ideation substance abuse heart failure renal failure

Question:

Contraindication for A2 delta ligands

Answer:

myopathy avoid prescribing concurrently wiht benzo

Question:

What is the onset of action for pregabalin in anxiety

Answer:

similar to onset of alprazolam

• / 4